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Crude synaptic membranes of avian and mammalian brain tissue were photolabeled with the benzodiazepine-receptor 
ligand PH]flunitrazepam and subsequently treated extensively with trypsin followed by incubation with endoglycosidase 
F. SDS-polyacrylamide gel electrophoresis and fluorography revealed that the final tryptic degradation product of 25 
kDa in both pigeon and calf brain is deglycosylated in two steps. These results were confirmed by immunoblots of similar- 
ly pretreated membranes of pig brain using the a-subunit-specific monoclonal antibody bd-24. Benzodiazepine-receptor 
binding and its enhancement by GABA are largely retained after trypsinization. Based on the proposed transmembrane 
topology for the a-subunits of the GABA/benzodiazepine receptor, we suggest that the large N-terminal domain of benzo- 
diazepine-binding proteins is protected against ryptic cleavage. 
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1. INTRODUCTION 
The GABA/benzodiazepine receptor ionophore 
complex (GABA/BZR) in mammals is presumably 
composed of two a- and two ,&subunits [11. The cr- 
subunit can be photolabeled with [3H]flunitraze- 
pam (FNZ) [2]. The photolabeled benzodiazepine 
(BZ)-binding proteins show species variation and 
regional heterogeneity [3,4] of the apparent mole- 
cular masses even after deglycosylation [5] as 
revealed by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE) followed by fluorography. In mam- 
mals, the main photolabeled BZ-binding protein of 
53 kDa is deglycosylated to 49 kDa, a value which 
corresponds to that of the amino acid chain of the 
a-subunit as deduced from its cDNA [6]. Since the 
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BZ-binding protein is deglycosylated in two steps, 
both potential glycosylation sites present in the 
amino acid chain of the a-subunit [6] appear to be 
glycosylated in vivo. 
After tryptic degradation of the BZ-binding pro- 
teins a photolabeled 40 kDa peptide is detectable 
in various species. In avians and mammals high 
concentrations of trypsin lead to further degrada- 
tion to a product of 25 kDa [7]. Treatment of tryp- 
tically degraded membranes with endoglycosidase 
F (Endo F) should clarify whether the 40 and 
25 kDa fragments are glycosylated. This informa- 
tion will help to localize approximately the tryptic 
cleavage sites with regard to the proposed 
transmembrane topology of the a-subunit [6]. 
Therefore, the size of the trypsinized and/or 
deglycosylated photolabeled BZ-binding proteins 
from various species was determined by SDS- 
PAGE followed by fluorography. In addition, im- 
munoblots of similarly pretreated membranes of 
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pig brain were performed using the a-subunit- 
specific monoclonal antibody (mAb) bd-24 [8], 
which cross-reacts with the pig brain a-subunit 
[9,10]. Thereby the molecular masses and LY- 
subunit specificity of the photolabeled fragments 
could be assessed. 
2. MATERIALS AND METHODS 
Pigeon, pig and calf were obtained locally. [‘H]FNZ (spec. 
act. 81.8 Ci/mmol) and Improved En3hance were from NEN. 
The enzyme endoglycosidase F (EC 3.2.1.96) was purchased 
from Boehringer Biochemica (Mannheim). 
Brains were removed immediately after death or after 2 (pig) 
or 4 h (calf), rapidly frozen and stored at - 70°C. Cortices and 
cerebella were investigated separately. 
Membrane preparations, photoaffinity labeling with 
[‘H]FNZ and fluorography were performed as described [3]. 
Briefly, crude synaptic membranes were prepared by 
homogenizing and washing the membranes four times in 
50 mM Tris-citrate buffer (PH 7.1), containing protease in- 
hibitors. Incubation (90 min in the dark) and irradiation 
(10 min at a wavelength of 366 nm and a distance of 3 cm; 
Camag de Luxe) were performed in an ice-water bath in 50 mM 
Tris-citrate buffer containing 150 mM NaCl, the protease in- 
hibitors and 10 nM [‘H]FNZ in the presence and absence of 
3 pM clonazepam. 
Tryptic degradation was performed as in [7]. After 
photolabeling membrane pellets were resuspended in 50 mM 
sodium phosphate buffer (pH 7.4) (0.2-0.5 mg/ml protein) 
containing different concentrations of trypsin (O-O.5 mg/ml). 
The suspensions were incubated for 30 min at 37°C in a water 
bath under shaking. Tryptic degradation was terminated by 
centrifugation at 48000 x g for 20 min at 4°C followed by 
washing the suspensions twice with buffer containing soybean 
trypsin inhibitor (1 mg/ml). 
For deglycosylation experiments, membranes (some of them 
after tryptic degradation) were resuspended in 25 mM Tris-HCl 
(pH 7.4), containing 0.2% SDS (0.5-l mg/ml protein) and in- 
cubated with various concentrations of Endo F (0.025- 
1.25 U/ml) for 18 h at 37°C according to Schmitz et al. [S]. 
SDS-PAGE of the photolabeled membrane proteins was per- 
formed on 10% polyacrylamide gels. Gels were fixed, im- 
pregnated with Improved En3hance, dried and exposed to 
Kodak X-Omat AR films for 2-4 weeks at -70°C. 
For immunoblotting, both pretreated (trypsin, Endo F or 
combination thereof) and untreated membrane proteins of pig 
brain were separated by SDS-PAGE, blotted on 0.45 pm 
nitrocellulose sheets according to Towbin et al. [ll] and in- 
cubated with the o-subunit-specific mAb bd-24 for 12 h at 4°C. 
Non-specific staining was determined with antibody-free 
culture medium. Antibody binding was visualized using the 
streptavidin-biotinylated peroxidase complex (Amersham) and 
3-amino-9-ethylcarbazole as substrate. 
Reversible binding studies on pretreated (trypsin and/or En- 
do F) or untreated membranes of calf cortex and pigeon 
telencephalon were performed with [3H]FNZ in 50 mM Tris- 
citrate buffer (pH 7.1), containing 150 mM NaCl using 6 con- 
centrations of [‘HIFNZ (0.2-10 nM) in the absence or presence 
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of 3 FM clonazepam. Specific binding was defined as the dif- 
ference in amount of [‘H]FNZ bound in the absence and 
presence of 3 pM clonazepam. Additional binding studies were 
performed in the presence of 1OL~M GABA. To ensure that 
tryptic degradation or deglycosylation of the BZ-binding pro- 
teins in calf cortex was complete prior to the reversible [3H]FNZ 
binding studies, identically pretreated membranes were 
photolabeled in parallel and visualized fluorographically. Pro- 
tein concentrations were determined with a modified method of 
Lowry et al. [12]. 
3. RESULTS 
In accordance with previous results [7,13], tryp- 
sinization of pig cortex membranes converted the 
main photolabeled BZ-binding proteins of 53 kDa 
and the weakly labeled proteins of 56 and 59 kDa 
led to labeled proteolytic products of 45, 40 and 
25 kDa (fig.1). The 53 kDa protein is tryptically 
degraded to 25 kDa via the intermediate product 
of 40 kDa [7]. The origin of the 45 kDa product, 
which under our labeling conditions is detectable 
only in cortex, is unclear. It is apparently not fur- 
ther degraded to 25 kDa. 
When trypsinized membranes were subsequently 
treated with low Endo F concentrations (0.25 U/ 
ml) the molecular mass of the 25 kDa product was 
reduced by approx. 2 kDa; incubation with a 
higher Endo F concentration (1.25 U/ml) led to 
further degradation to 21 kDa. Thus, the pro- 
teolytic product of 25 kDa is a glycopeptide, which 
is deglycosylated in two steps. We had previously 
shown that deglycosylation of all strongly labeled 
BZ-binding proteins in different vertebrates also 
reduces the molecular mass in two steps of approx. 
2 kDa each [5]. The deglycosylation pattern of 
weakly and/or diffusely labeled bands, such as 
those of 56 and 59 kDa in pig cortex (fig, l), cannot 
be evaluated properly. The deglycosylated pro- 
teolytic products of 45 and 40 kDa are not discer- 
nible in fig.1. In pig cerebellum, the 25 kDa 
peptide is also deglycosylated to 21 kDa (not 
shown). 
In order to determine the subunit of origin giv- 
ing rise to the various degradation products, im- 
munoblots were performed with the a-subunit- 
specific mAb bd-24. In addition to an original 
53 kDa protein the two tryptic degradation prod- 
ucts of 40 and 25 kDa were specifically immuno- 
stained in both pig cortex (fig.2) and cerebellum 
(not shown). When Endo F was added subsequent 
to trypsinization, the 53 kDa protein and its pro- 
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Fig.1. SDS-PAGE and fluorography of pig cortex membranes. 
Membranes were photolabeled with [3H]FNZ, left untreated 
(U) or subsequently treated with trypsin (0.5 mg/ml) and/or 
different concentrations of Endo F, respectively. All bands are 
labeled specifically (nonspecific binding not shown). Here and 
in figs 2,3, numbers (in kDa) indicate apparent molecular 
masses which are calibrated with standard proteins. 
teolytic products of 40 and 25 kDa were 
deglycosylated in two steps as shown by immuno- 
staining (fig.2). The respective molecular masses 
were indistinguishable from those determined 
fluorographically. These results show that the pro- 
tein bands of 40 and 25 kDa contain tryptic 
fragments of the a-subunit and that the 
deglycosylation pattern observed is that of the cy- 
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subunit. The weakly photolabeled bands of 56 and 
59 kDa as well as the photolabeled tryptic degrada- 
tion product of 45 kDa were not stained by bd-24. 
To compare the degradation products obtained 
in mammalian brain with those of avian brain, the 
receptor in pigeon telencephalon was investigated. 
We had previously shown that the tryptic degrada- 
tion products in avian telencephalon (45, 40, 
25 kDa) and cerebellum (40, 25 kDa) have a 
molecular mass similar to those obtained in mam- 
malian cortex and cerebellum, respectively [7]. We 
now show that in pigeon telencephalon the 
molecular masses of all photolabeled proteolytic 
products (45, 40 and 25 kDa) were reduced in two 
steps by deglycosylation (fig.3). Similarly, in 
pigeon cerebellum the proteolytic product of 
25 kDa was also deglycosylated to 21 kDa (not 
shown). 
In order to investigate the effect of trypsiniza- 
tion and/or deglycosylation of BZ-binding pro- 
teins on binding parameters, reversible binding 
studies were performed with [‘H]FNZ (table 1). 
Trypsinization slightly reduced the Bmax value (ex- 
pressed as fmol/mg protein) in membranes of calf 
cortex whereas that of pigeon telencephalon re- 
mained virtually unchanged. Deglycosylation with 
Endo F resulted in significant reduction of the B,, 
values in calf membranes, a decrease being also 
observed in pigeon telencephalon. The combined 
treatment with trypsin and Endo F did not 
significantly lower the B,,,,, values beyond the 
values obtained in membranes pretreated with En- 
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Fig.2. Immunological detection of proteins recognized by the ,x-subunit-specific mAb bd-24 in pig cortex. Membranes were left 
untreated (U) or treated with trypsin (0.5 mg/ml) and/or different concentrations of Endo F, respectively, and subsequently subjected 
to SDS-PAGE and immunoblotting. Nonspecific staining (a) was determined using the antibody-free culture medium for incubation. 
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U T T+E Table 1 
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Fig.3. SDS-PAGE and fluorography of 
U/ml 
telencephalic 
membranes of pigeon brain. Membranes were photolabeled 
with [3H]FNZ, left untreated (U) or subsequently treated with 
trypsin (0.5 mg/ml) and/or different concentrations of Endo F, 
respectively. 
do F alone. The & values of the untreated and 
pretreated membranes were similar. To ascertain 
that tryptic digestion had occurred prior to the 
ligand-binding experiments calf cortex mem- 
branes, which were pretreated identically to those 
used for the reversible binding studies with trypsin 
or Endo F, were subsequently photolabeled and 
subjected to SDS-PAGE. Fluorography of the 
trypsinized membranes revealed labeling of mainly 
the proteolytic product of 25 kDa and to a lesser 
extent those of 45 and 40 kDa. The pattern was 
compatible with that observed upon degradation 
with a high concentration of trypsin. Thus, reversi- 
ble binding primarily occurred to the fragment of 
25 kDa. When calf cortex membranes were treated 
with Endo F alone prior to the reversible binding 
study, the carbohydrate moieties were completely 
removed as shown fluorographically by the reduc- 
tion in size of the 53 kDa band to one of 49 kDa 
(not shown). Thus, we were able to ensure that the 
reversible binding studies had been performed with 
either the fully deglycosylated tryptic fragment of 
the receptor or deglycosylated receptor. Our 
results confirm that the proteolytic products can 
bind t3H]FNZ reversibly and irreversibly [ 131. The 
same applies to the deglycosylated BZ-binding pro- 
teins. Furthermore, reversible [3H]FNZ binding 
was enhanced by GABA to a similar extent in en- 
Comparison of binding parameters of reversible [3H]flunitra- 
zepam binding and its enhancement by 1OOrM GABA in 
untreated or pretreated (trypsin and/or endoglycosidase F) 
brain membranes (results are of single determinations) 
Membranes B max Kd WI) 
(fmol/mg 
protein) - GABA + GABA 
(100 rM) 
(A) Calf cortex 
Untreated 
Trypsinized 
Deglycosylated 
Trypsinized and 
deglycosylated 
(B) Pigeon telencephalon 
Untreated 
Trypsinized 
Deglycosylated 
Trypsinized and 
deglycosylated 
1433 2.9 1.6 
1090 4.6 2.8 
466 3.2 1.7 
461 2.8 0.9 
1127 2.1 
1136 2.1 
892 3.8 
622 3.4 
zymatically pretreated and untreated membranes 
of calf cortex (table 1). 
4. DISCUSSION 
Tryptic degradation products of the photola- 
beled BZ-binding proteins, which can be detected 
fluorographically, are glycopeptides. In pig cortex 
(fig.1) and cerebellum the molecular mass of the 
25 kDa fragment is reduced by approx. 4 kDa by 
deglycosylation. Similar to the main BZ-binding 
protein of 53 kDa [5], deglycosylation of the 
25 kDa tryptic fragment proceeds in two steps 
(fig.1). Low concentrations of Endo F apparently 
may cleave one carbohydrate chain of 2-3 kDa; 
higher concentrations may remove an additional 
carbohydrate moiety of similar size. Similarly, in 
avian telencephalon deglycosylation of both the 45 
and 25 kDa fragments also occurs in two steps as 
visualized by fluorography (fig.2). Deglycosylation 
in two steps of the tryptic degradation products of 
40 and 25 kDa was also demonstrated by immuno- 
blotting using the a-subunit-specific mAb bd-24 
(fig.2). The results indicate that the 40 and 25 kDa 
fragments are derived from the a-subunit of 
GABA/BZR. In accordance with previous results 
[ 131 the tryptic degradation products can be label- 
ed reversibly and irreversibly, indicating that they 
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encompass both the reversible BZ-binding site and 
the irreversible binding site for [3H]FNZ (table 1). 
Not all photolabeled proteins were immunoreac- 
tive with the mAb bd-24. The photolabeled 56 and 
59 kDa BZ-binding proteins in pig cortex could 
represent additional a-subunits, which escape im- 
munodetection with the mAb bd-24 [14]. In accor- 
dance with this assumption, it was recently found 
that these proteins can be immunostained with the 
a-subunit-specific mAb bd-28 [8,15]. The frag- 
ment of 45 kDa labeled in pig cortex possibly 
results from tryptic degradation of the 56 and 
59 kDa proteins, thus explaining why it also 
escapes immunodetection. 
The a-subunit of the GABA/BZR from bovine 
[6] and rat brain [16,17] is believed to consist of a 
large extracellular N-terminus followed by four 
transmembrane regions (Ml-M4) and a short ex- 
tracellular C-terminus region. The main BZ- 
binding protein (53 kDa) in pig brain seems to 
share homologies with the bovine and rat cy- 
subunits as shown by its size. Additionally, both 
the bovine and pig a-subunits immunoreact with 
bd-24. Assuming that the pig cu-subunit also con- 
tains two potential glycosylation sites, our results 
suggest that the large extracellular N-terminal do- 
main containing the glycosylation sites is protected 
against tryptic proteolysis. This 25 kDa peptide 
fragment may encompass most, if not all, of the 
extracellular domain. The 40 kDa glycopeptide 
fragment might additionally encompass Ml-M3 
and part of the intracellular loop between M3 and 
M4. Accordingly, the tryptic cleavage site leading 
to the 40 kDa glycopeptide may be localized in- 
tracellularly between M3 and M4. 
Since low trypsin concentrations lead to the 
40 kDa peptide in several vertebrates despite varia- 
tion in the original molecular masses of the BZ- 
binding proteins [7], we propose that the bulk of 
the photolabeled BZ-binding proteins is structural- 
ly homologous between species. Accordingly, the 
variation in molecular masses of the original BZ- 
binding proteins should be due to structural 
changes in the intracellular loop between M3 and 
M4, or at the C-terminus. 
It seems urprising that the large extracellular N- 
terminal domain is protected against cleavage even 
at high trypsin concentrations. However, the 
preservation of the BZ-binding site which is 
thought to be located in the extracellular domain 
supports this conclusion (table 1): (i) the 25 kDa 
peptide encompasses most of the reversible and ir- 
reversible binding sites for [‘HIFNZ; (ii) reversible 
binding of [3H]FNZ could be enhanced by GABA 
in membranes pretreated with high trypsin concen- 
trations to an extent comparable with fresh mem- 
branes (table 1). Radioligand binding occurs 
mainly to the 25 kDa peptide, since photolabeling 
and SDS-PAGE of trypsinized membranes re- 
vealed the fragment as the main degradation pro- 
duct. The fact that reversible binding of [3H]FNZ 
to the 25 kDa fragment can be enhanced by GABA 
suggests that a low-affinity GABA-binding site 
may also be located on the 25 kDa fragment. 
Recently, a structural basis for the heterogeneity 
of the GABA* receptor has become apparent 
through the isolation of additional cDNA clones 
encoding proteins closely related to the a-subunit 
[ 16,181. The deduced amino acid sequences of the 
additional cDNAs [18] encompass more than two 
potential sites for N-linked glycosylation. How- 
ever, it is unclear as to what extent the correspon- 
ding proteins are expressed in brain and whether 
they are susceptible to photolabeling with 
[3H]FNZ. Our results suggest that in vertebrates 
most, if not all, subunits which are strongly 
photolabeled with [3H]FNZ may encompass two 
glycosylation sites in vivo [5]. Since the size of the 
main tryptic degradation products of the BZ- 
binding proteins is phylogenetically conserved the 
photolabeled proteins appear to be structurally 
homologous. Intraspecies and interspecies varia- 
tion in molecular masses of BZ-binding proteins 
may result from structural differences in the in- 
tracellular loop between M3 and M4 or at the C- 
terminus. 
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